卵巢癌FIGO分期适用于卵巢癌
AmericanJointCommitteeonCancer(AJCC)
TNMandFIGOStagingSystemforOvarian,FallopianTube,andPrimaryPeritonealCancer(8thed.,)
卵巢癌、输卵管癌和原发性腹膜癌TNM分期和FIGO分期年8版
TNM
FIGO
TX
Primarytumorcannotbeassessed
原发肿瘤不可评估
T0
Noevidenceofprimarytumor
没有原发肿瘤
T1
Ⅰ
Tumorlimitedtoovaries(oneorboth)orfallopiantube(s)
肿瘤局限于卵巢（单侧或者双侧）或者输卵管。
T1a
ⅠA
Tumorlimitedtooneovary(capsuleintact)or
fallopiantube,notumoronovarianorfallopiantubesurface;nomalignantcellsinascitesorperitonealwashings
肿瘤局限于单侧卵巢（囊壁完好）或输卵管，并且卵巢和输卵管表面无肿瘤，并且腹水或者腹腔冲洗液无肿瘤细胞。
T1b
ⅠB
Tumorlimitedtobothovaries;(capsulesintact)orfallopiantubes;notumoronovarianorfallopiantubesurface;nomalignantcellsinascitesorperitonealwashings
肿瘤局限于双侧卵巢（囊壁完好）或输卵管，并且卵巢和输卵管表面无肿瘤，并且腹水或者腹腔冲洗液无肿瘤细胞。
T1c
ⅠC
Tumorlimitedtooneorbothovariesorfallopian
tubes,withanyofthefollowing:
肿瘤局限于单侧或双侧卵巢或者输卵管，合并以下任一情况：
T1c1
ⅠC1
Surgicalspill
术中肿瘤破裂
T1c2
ⅠC2
Capsulerupturedbeforesurgeryortumoronovarianorfallopiantubesurface
术前肿瘤自发破裂，或者卵巢或输卵管表面有肿瘤
T1c3
ⅠC3
Malignantcellsinascitesorperitonealwashings
腹水或腹腔冲洗液有恶性细胞（细胞学阳性）
T2
Ⅱ
Tumorinvolvesoneorbothovariesorfallopiantubeswithpelvicextensionbelowpelvicbrimorprimaryperitonealcancer
肿瘤累及单侧或双侧卵巢或输卵管，伴盆腔内扩散未超出盆腔上缘或者原发性腹膜癌（局限于盆腔内）
T2a
ⅡA
Extensionand/orimplantsontheuterusand/orfallopiantube(s)and/orovaries
子宫和/或输卵管和/或卵巢的扩散和/或种植（未超出子宫双附件）
T2b
ⅡB
Extensiontoand/orimplantsonotherpelvictissues
扩散和/或种植到盆腔内其他组织（超出子宫双附件）
T3
Ⅲ
Tumorinvolvesoneorbothovariesorfallopiantubes,orprimaryperitonealcancer,withmicroscopicallyconfirmedperitonealmetastasisoutsidethepelvisand/ormetastasistotheretroperitoneal(pelvicand/orpara-aortic)lymphnodes
肿瘤累及一侧或双侧卵巢或输卵管，或原发性腹膜癌，伴有镜下证实的盆腔外腹膜转移和/或腹膜后(盆腔和/或腹主动脉旁)淋巴结转移（肿瘤累及盆腔以外）
T1/T2N1
ⅢA1
Positiveretroperitoneallymphnodesonly(histologicallyconfirmed)
仅腹膜后阳性淋巴结(组织学证实)
T1/T2
N1a
ⅢA1i
Metastasisuptoandincluding10mmingreatestdimension
仅腹膜后淋巴结阳性，病灶最大直径≤10mm
T1/T2
N1b
ⅢA1ii
Metastasismorethan10mmingreatestdimension
仅腹膜后淋巴结阳性，病灶最大直径＞10mm
T3a
ⅢA2
Microscopicextrapelvic(abovethepelvicbrim)peritonealinvolvementwithorwithoutpositiveretroperitoneallymphnodes
镜下肿瘤超出盆腔腹膜（骨盆上缘以上），伴或不伴腹膜后淋巴结阳性
T3b
ⅢB
Macroscopicperitonealmetastasisbeyondpelvis2cmorlessingreatestdimensionwithorwithoutmetastasistotheetroperitoneallymphnodes
盆腔外腹膜肉眼可见肿瘤转移灶，最大直径≤2cm，伴或不伴腹膜后淋巴结转移
T3c
ⅢC
Macroscopicperitonealmetastasisbeyondthepelvismorethan2cmingreatestdimensionwithorwithoutmetastasistotheretroperitoneallymphnodes(includesextensionoftumortocapsuleofliverandspleenwithoutparenchymalinvolvementofeitherorgan)
盆腔外腹膜可见肿瘤转移灶最大直径＞2cm，伴或不伴腹膜后淋巴结转移（包括肝包膜、脾包膜的肿瘤，没有任何脏器实质的受累。）
M1
Ⅳ
Distantmetastasis,includingpleuraleffusionwithpositivecytology;liverorsplenicparenchymalmetastasis;metastasistoextra-abdominalorgans(includinginguinallymphnodesandlymphnodesoutsidetheabdominalcavity);andtransmuralinvolvementofintestine
远处转移，包括胸腔积液细胞学阳性、肝或脾实质转移、转移至腹腔外脏器（包括腹股沟淋巴结和腹腔以外的淋巴结）、肠道的透壁侵犯。
M1a
ⅣA
Pleuraleffusionwithpositivecytology
胸腔积液细胞学阳性
M1b
ⅣB
Liverorsplenicparenchymalmetastases;metastasestoextra-abdominalorgans(includinginguinallymphnodesandlymphnodesoutsidetheabdominalcavity);transmuralinvolvementofintestine
肝或脾实质转移、转移至腹腔外脏器（包括腹股沟淋巴结和腹腔以外的淋巴结）、肠道的透壁侵犯
预览时标签不可点收录于话题#个上一篇下一篇
